Join Us for Canines & Cocktails on December 10, 2026! Click Here to Buy Tickets.

02171-MOU: Histiocytic Sarcoma in Bernese Mountain Dogs: Novel Approaches To Treatment

Canine histiocytic sarcoma (HS) is a highly aggressive cancer that affects Bernese Mountain Dogs (BMD), with a particularly high prevalence rate that ranges from 15 to 25% of the population. The current treatment options for HS are based on the administration of conventional chemotherapeutic drugs, to which dogs respond poorly and only for a short […]

01093A: Positional Cloning of the Gene(s) for Gastric Cancer in the Chow Chow

Several canine breeds including Chow Chows, Belgian Sheepdogs and Tervuren, Keeshonden, Norwegian elkhounds, Akitas, Eurasiers, and Scottish Terriers have an increased risk on developing gastric carcinoma (stomach cancer). Furthermore, examination of pedigrees suggests that this cancer may result from a faulty gene or genes. Our goal is to identify the gene(s) that predispose this cancer […]

00878-A: MicroRNA Expression in the Domestic Dog and Its Role in Canine Cancer

A new group of genes, termed microRNAs, have been discovered to be associated with various cancers in the human. These genes are also found in dogs and have the exact same sequence as the human counterparts. Due to the great similarity between the human and dog, we hypothesize that these genes may also play a […]

01557: Narrowing the Search for the Genetic Basis of Histiocytic Malignancies

In a previous study (CHF-760) Dr. Breen demonstrated that canine histiocytic malignancies (HMs) present with a high degree of DNA copy number alterations. His research group identified several aberrant regions of the genome that are highly recurrent between cases, suggesting that such regions are associated causally with the malignant process. Understanding the biology of genes […]

02405-A: Transcriptome Based Diagnostics in Canine Soft Tissue Sarcoma

Sarcomas are malignant cancers that can arise in any part of the body; however, in the dog, a subset referred to as soft tissue sarcomas account for 10-15% of all skin and subcutaneous cancers. Traditionally biopsy and subsequent histology have been the primary means of diagnosing these cancers. The histology is assigned to one of […]